Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Georgetown University

🇬🇹Guatemala

Country: 🇬🇹Guatemala

Ownership: Private

Established: 1789-01-23

Employees: 5K

Market Cap: -

Website: http://www.georgetown.edu

Clinical Trials

Phase IB/II of CPX-351 for Relapse Prevention in AML

Phase 1

Recruiting

Conditions: Acute Myeloid Leukemia (AML) in Remission

Interventions: Drug: CPX-351

First Posted Date: 2021-08-04

Last Posted Date: 2025-03-25

Lead Sponsor: Georgetown University

Target Recruit Count: 24

Registration Number: NCT04990102

Locations: 🇺🇸
Georgetown Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States
🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

Phase 2

Recruiting

Conditions: Non-squamous Non-small-cell Lung Cancer

Interventions: Drug: Tiragolumab
Drug: Atezolizumab
Drug: Bevacizumab

First Posted Date: 2021-07-12

Last Posted Date: 2025-03-24

Lead Sponsor: Georgetown University

Target Recruit Count: 42

Registration Number: NCT04958811

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, United States

Pembrolizumab and Lenvatinib in Advanced Cervical Cancer

Phase 2

Recruiting

Conditions: Metastatic Cervical Cancer
Cervical Cancer

Interventions: Drug: Pembrolizumab
Drug: Lenvatinib

First Posted Date: 2021-04-29

Last Posted Date: 2025-05-09

Lead Sponsor: Georgetown University

Target Recruit Count: 35

Registration Number: NCT04865887

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸
Medstar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
Georgia Cancer Center at Augusta University, Augusta, Georgia, United States

and more 1 locations

Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairment

Early Phase 1

Completed

Conditions: Cirrhosis, Liver

Interventions: Drug: Proglumide

First Posted Date: 2021-03-24

Last Posted Date: 2022-03-15

Lead Sponsor: Georgetown University

Target Recruit Count: 11

Registration Number: NCT04814602

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer
Metastatic Breast Cancer
Hormone Receptor Positive Breast Carcinoma

Interventions: Drug: SM-88

First Posted Date: 2021-01-22

Last Posted Date: 2023-08-28

Lead Sponsor: Georgetown University

Target Recruit Count: 11

Registration Number: NCT04720664

Locations: 🇺🇸
MedStar Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, District of Columbia, United States
🇺🇸
MedStar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
MedStar Franklin Square Medical Center, Baltimore, Maryland, United States

and more 2 locations

A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening

Not Applicable

Recruiting

Conditions: Lung Cancer

Interventions: Behavioral: Provider Prompt & Patient Outreach and Education

First Posted Date: 2020-12-19

Last Posted Date: 2024-12-27

Lead Sponsor: Georgetown University

Target Recruit Count: 368

Registration Number: NCT04675476

Locations: 🇺🇸
MedStar Health, Washington, District of Columbia, United States

Pharmacokinetics and Pharmacogenomics of Ribociclib in Race-based Cohorts

Phase 4

Terminated

Conditions: Breast Cancer

Interventions: Drug: Ribociclib

First Posted Date: 2020-12-08

Last Posted Date: 2024-11-26

Lead Sponsor: Georgetown University

Target Recruit Count: 21

Registration Number: NCT04657679

Locations: 🇺🇸
MedStar Georgetown University Hospital, Washington, District of Columbia, United States
🇺🇸
Medstar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
Tufts Medical Center, Boston, Massachusetts, United States

Reducing Perioperative S. Aureus Transmission Via OR PathTrac

Completed

Conditions: S. Aureus Transmission
Surgical Site Infection

Interventions: Other: OR PathTrac Feedback Optimization

First Posted Date: 2020-12-08

Last Posted Date: 2020-12-08

Lead Sponsor: Georgetown University

Target Recruit Count: 804

Registration Number: NCT04657185

Locations: 🇺🇸
Georgetown University, Georgetown, District of Columbia, United States

Online Trial of Meditation and Behavior

Not Applicable

Completed

Conditions: Meditation

Interventions: Behavioral: Loving-Kindness Meditation
Behavioral: Relaxation Meditation

First Posted Date: 2020-11-17

Last Posted Date: 2021-06-14

Lead Sponsor: Georgetown University

Target Recruit Count: 75

Registration Number: NCT04632875

Locations: 🇺🇸
Georgetown University, Washington, District of Columbia, United States

Same-Day Discharge After Nipple-sparing Mastectomy or Skin-sparing Mastectomy With Breast Reconstruction

Not Applicable

Conditions: Mastectomy; Lymphedema
Breast Cancer
Same Day Surgery
Skin-sparing Mastectomy
Nipple-sparing Mastectomy

Interventions: Procedure: Same-day NSM or SSM

First Posted Date: 2020-10-22

Last Posted Date: 2020-10-22

Lead Sponsor: Georgetown University

Target Recruit Count: 60

Registration Number: NCT04596683

Locations: 🇺🇸
Medstar Georgetown University, Washington, District of Columbia, United States
🇺🇸
Medstar Washington Hospital Center, Washington, District of Columbia, United States
🇺🇸
Medstar Franklin Square Medical Center, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy